Carcinine (beta-Alanylhistamine) is a selective and orally active histamine H3 receptor antagonist with a Ki of 0.2939 µM. Carcinine can reduce histamine content. Carcinine exhibits anti-oxidant activity and neuroprotective effects. Carcinine shows positive inotropic effect and can reduce blood sugar and blood lipid levels. Carcinine can be used for the researches of inflammation, neurological, cardiovascular and metabolic disease, such as retinal damage, seizure and diabetes[1][2][3][4][5].
Molecular Weight:
182.22
CAS Number:
[56897-53-1]
Formula:
C8H14N4O
Target:
Histamine Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
